drugset / Trial / NCT03471507

Bonipar for Acute and Chronic Musculoskeletal Pain

NCT03471507

Phase 2 Completed 164 enrolled Winston Parris, MD
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is a non-inferiority study comparing efficacy and onset of action between the herbal extracts topical solution, Bonipar, and diclofenac sodium topical solution, diclofenac topical solution 1.5%.

Timeline

Start
2020-12-15
Primary completion
2022-09-22
Completion
2022-09-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Bonipar Traditional medicine (herbal / TCM) Topical
Comparator Diclofenac Other / unclassified 1.5 % Topical